Top compounds associated with response to TAS2R30


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.015 0.7
mRNA BRD-K85133207 CTRPv2 pan-cancer AAC 0.016 0.7
mRNA regorafenib CTRPv2 pan-cancer AAC -0.016 0.7
mRNA silmitasertib CTRPv2 pan-cancer AAC 0.016 0.7
mRNA Zebularine CTRPv2 pan-cancer AAC 0.014 0.7
mRNA UNC0638 CTRPv2 pan-cancer AAC 0.015 0.7
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.015 0.7
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC 0.014 0.7
mRNA LRRK2-IN-1 CTRPv2 pan-cancer AAC -0.015 0.7
mRNA MLN4924 CTRPv2 pan-cancer AAC 0.014 0.7
Download CSV